Clinical Trial Update: A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating transitioning adults with opioid dependence from daily sublingual buprenorphine to Probuphine subdermal implants; completed with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Probuphine (buprenorphine implant)

Snippet

Sponsor: Titan Pharmaceuticals | Conditions: Opioid Dependence | Phase 3 | Status: COMPLETED | Results posted: 2018-12-05